ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,929Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 336

$1.95M Total Retail Price of All Prescriptions

Rank: 5 out of 336

832 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 832 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

13% of this provider’s 832 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 21,918 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
SIMVASTATIN 1,196 969 1 5
AMLODIPINE BESYLATE 924 776 2 1
LISINOPRIL 856 716 3 6
OMEPRAZOLE 842 655 4 3
FUROSEMIDE 837 642 5 4
METFORMIN HCL 800 611 6 8
LEVOTHYROXINE SODIUM 625 521 7 7
ATORVASTATIN CALCIUM 572 435 8 14
CARVEDILOL 569 434 9 13
GABAPENTIN 565 401 10 11
CRESTOR 523 409 11 25
POTASSIUM CHLORIDE 468 368 12 9
METOPROLOL SUCCINATE 464 388 13 15
LOSARTAN POTASSIUM 450 395 14 22
HYDROCODONE-ACETAMINOPHEN 433 237 S3 15 2
CYMBALTA 409 215 16 52
CLOPIDOGREL 397 344 17 28
CITALOPRAM HBR 390 305 18 21
WARFARIN SODIUM 380 316 19 17
GLIMEPIRIDE 355 298 20 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 311 230 21 23
FENOFIBRATE 299 206 22 72
ZETIA 295 197 23 74
DONEPEZIL HCL 291 286 24 27
PLAVIX 290 248 25 37
METOPROLOL TARTRATE 270 237 26 16
HYDROCHLOROTHIAZIDE 265 227 27 12
SERTRALINE HCL 263 195 28 33
TAMSULOSIN HCL 259 232 29 38
PRAVASTATIN SODIUM 236 216 30 10
NAMENDA 226 214 31 39
TRAMADOL HCL 224 194 32 20
DOXAZOSIN MESYLATE 223 183 33 86
ALLOPURINOL 222 190 34 30
NEXIUM 217 109 35 24
ENALAPRIL MALEATE 204 166 36 60
TRAZODONE HCL 204 167 36 46
PANTOPRAZOLE SODIUM 202 134 38 40
ZOLPIDEM TARTRATE 192 141 39 18
JANUVIA 181 142 40 67
DIOVAN 164 117 41 31
ATENOLOL 159 153 42 26
DIGOXIN 153 153 43 50
LIPITOR 150 112 44 62
AMITRIPTYLINE HCL 149 95 R 45 57
RANITIDINE HCL 136 119 46 36
PAROXETINE HCL 134 122 47 64
TRICOR 127 98 48 108
SINGULAIR 125 67 49 85
TIZANIDINE HCL 123 64 50 83
ABILIFY 122 74 51 169
QUETIAPINE FUMARATE 120 102 52 94
BENAZEPRIL HCL 119 110 53 59
BUPROPION HCL SR 118 92 54 199
LOVAZA 117 83 55 157
ALENDRONATE SODIUM 116 113 56 54
FLUOXETINE HCL 116 70 56 81
RAMIPRIL 115 96 58 84
CYCLOBENZAPRINE HCL 112 56 R 59 65
FINASTERIDE 111 108 60 156
MONTELUKAST SODIUM 110 63 61 140
VYTORIN 109 92 62 122
SPIRONOLACTONE 108 93 63 42
BYSTOLIC 106 80 64 79
LOSARTAN-HYDROCHLOROTHIAZIDE 105 99 65 45
PRAMIPEXOLE DIHYDROCHLORIDE 102 79 66 204
ADVAIR DISKUS 100 72 67 82
DIOVAN HCT 98 57 68 41
BUSPIRONE HCL 95 52 69 113
MECLIZINE HCL 92 88 70 96
SYNTHROID 88 76 71 43
FLUTICASONE PROPIONATE 88 51 71 49
AMLODIPINE BESYLATE-BENAZEPRIL 86 78 73 47
TRIAMTERENE-HCTZ 84 65 74 35
LANTUS 82 57 75 56
EXELON 81 72 76 154
JANUMET 81 57 76 134
ONGLYZA 77 71 78 165
NATEGLINIDE 76 75 79 300
PREDNISONE 76 63 79 48
PREMARIN 76 49 R 79 131
GEMFIBROZIL 76 61 79 115
PROAIR HFA 76 44 79 77
AZITHROMYCIN 74 59 84 58
LANTUS SOLOSTAR 74 36 84 124
LANSOPRAZOLE 74 34 84 167
RISPERIDONE 73 45 87 90
LYRICA 72 43 88 70
ACETAMINOPHEN-CODEINE 72 46 S3 88 136
DIVALPROEX SODIUM 70 23 90 142
CEFUROXIME 69 56 91 177
ESCITALOPRAM OXALATE 69 44 91 69
PEN NEEDLE 68 13 93 162
SYMBICORT 67 45 94 155
MIRTAZAPINE 67 58 94 66
QUINAPRIL HCL 65 57 96 107
POLYETHYLENE GLYCOL 3350 64 47 97 68
DILTIAZEM 24HR CD 63 52 98 126
CIPROFLOXACIN HCL 62 53 99 55
SPIRIVA 62 38 99 88
OXYBUTYNIN CHLORIDE 62 62 99 153
HUMALOG 61 33 102 214
AVODART 59 59 103 188
VESICARE 56 49 104 190
LEVEMIR FLEXPEN 56 29 104 172
ACTOS 56 33 104 119
HUMULIN R 55 48 107 230
BACLOFEN 55 18 107 179
OLANZAPINE 54 21 109 178
LAMOTRIGINE 54 46 109 242
INSULIN SYRINGE 53 24 111 102
AMIODARONE HCL 52 52 112 117
SOTALOL 52 36 112 259
GLYBURIDE 51 43 R 114 76
ISOSORBIDE MONONITRATE ER 51 49 114 44
SAVELLA 51 16 114 315
VERAPAMIL ER 51 27 114 95
CELEBREX 51 29 114 105
MELOXICAM 50 29 119 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.